Relapsed/Refractory Paediatric Acute Leukaemia
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Paediatric Acute Leukaemia
| Record | Firm | Date |
|---|---|---|
| "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia (NCT02074657) | Hospital Universitario La Paz | 2014-04-01 |
Track Relapsed/Refractory Paediatric Acute Leukaemia automatically
Every clearance here is in the API, with alerts when new ones post.